亚洲 · 综合新闻 · CNA
India orders top drugmaker to halt eye medicine production at plant over quality lapses
Indian regulators have escalated action against India's largest drugmaker, Sun Pharma, barring ophthalmic drug production at its Assam factory until it submits a satisfactory…
在 CNA 阅读全文 登录后可收藏MarketNews 仅展示媒体发布的标题和摘要，全文请在出版方网站阅读。 (www.channelnewsasia.com)
